The ProxyLite brand, founded in 2010 (Switzerland), from 2 sister brands and 2214 competing brands. The ProxyLite brand is owned by Addex Therapeutics, a company listed in Zurich. The International Securities Identification Number (ISIN) of Addex Therapeutics is CH0029850754. ProxyLite belongs to the Biotechnology business sector.